SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Irwin DE, Milsom I, Hunskaar S et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006; 50: 130615
  • 2
    Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 7606
  • 3
    Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 32736
  • 4
    Chapple CR. Lower urinary tract symptoms suggestive of benign prostatic obstruction – triumph: design and implementation. Eur Urol 2001; 39 (Suppl. 3): 316
  • 5
    Garraway WM, Collins GN, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet 1991; 338: 46971
  • 6
    Verhamme KM, Dieleman JP, Bleumink GS et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the Triumph project. Eur Urol 2002; 42: 3238
  • 7
    Engstrom G, Walker-Engstrom ML, Loof L, Leppert J. Prevalence of three lower urinary tract symptoms in men – a population-based study. Fam Pract 2003; 20: 710
  • 8
    Malmsten UG, Milsom I, Molander U, Norlen LJ. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45–99 years. J Urol 1997; 158: 17337
  • 9
    Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 4749
  • 10
    Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005; 173: 125661
  • 11
    Anger JT, Saigal CS, Wang M, Yano EM. Urologic disease burden in the United States: veteran users of Department of Veterans Affairs healthcare. Urology 2008; 72: 3741
  • 12
    Naslund MJ, Issa MM, Grogg AL, Eaddy MT, Black L. Clinical and economic outcomes in patients treated for enlarged prostate. Am J Manag Care 2006; 12: S1116
  • 13
    Costa P, Mottet N. Assessing the impact of urinary incontinence in a female population. Eur Urol 1997; 32 (Suppl. 2): 257
  • 14
    Horchani A, Binous MY, Ben Hamida A, Sallami S, El Adbi H, Naji A. [Prevalence of benign prostatic hyperplasia in general practice and practical approach of the Tunisian general practitioner (Prevapt study)]. Tunis Med 2007; 85: 61924
  • 15
    Safarinejad MR. Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 2008; 40: 92131
  • 16
    Tuncay Aki F, Aygun C, Bilir N, Erkan I, Ozen H. Prevalence of lower urinary tract symptoms in a community-based survey of men in Turkey. Int J Urol 2003; 10: 36470
  • 17
    Apolone G, Cattaneo A, Colombo P, La Vecchia C, Cavazzuti L, Bamfi F. Knowledge and opinion on prostate and prevalence of self-reported BPH and prostate-related events. A cross-sectional survey in Italy. Eur J Cancer Prev 2002; 11: 4739
  • 18
    Heidler S, Deveza C, Temml C et al. The natural history of lower urinary tract symptoms in females: analysis of a health screening project. Eur Urol 2007; 52: 174450
  • 19
    Simeonova Z, Milsom I, Kullendorff AM, Molander U, Bengtsson C. The prevalence of urinary incontinence and its influence on the quality of life in women from an urban Swedish population. Acta Obstet Gynecol Scand 1999; 78: 54651
  • 20
    Hunskaar S, Lose G, Sykes D, Voss S. The prevalence of urinary incontinence in women in four European countries. BJU Int 2004; 93: 32430
  • 21
    Nitti V. Postprostatectomy Incontinence, 8th edn. Philadelphia, PA: Saunders, 2002
  • 22
    Shekarriz B, Upadhyay J, Wood DP. Intraoperative, perioperative, and long-term complications of radical prostatectomy. Urol Clin North Am 2001; 28: 63953
  • 23
    Peters TJ, Donovan JL, Kay HE et al. The International Continence Society ‘Benign Prostatic Hyperplasia’ Study: the bothersomeness of urinary symptoms. J Urol 1997; 157: 8859
  • 24
    Reynard JM, Yang Q, Donovan JL et al. The ICS-‘BPH’ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol 1998; 82: 61923
    Direct Link:
  • 25
    Abrams P, Cardozo L, Fall M et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61: 3749
  • 26
    Chapple CR, Wein AJ, Abrams P et al. Lower urinary tract symptoms revisited: a broader clinical perspective. Eur Urol 2008; 54: 5639
  • 27
    Mariappan P, Chong WL. Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: Results of a regional population-based survey and comparison with industrialized nations. BJU Int 2006; 98: 12648
  • 28
    Kaplan SA. Male pelvic health: a urological call to arms. J Urol 2006 2008; 176: 23512
  • 29
    Coyne KS, Sexton CC, Milsom I et al. The prevalence of lower urinary tract symptoms in the USA, the UK and Sweden: results from EpiLUTS. BJU Int 2009 (in press)
  • 30
    Kupelian V, Wei JT, O’Leary MP et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 2006; 166: 23817
  • 31
    Sexton CC, Coyne KS, Kopp ZS et al. The overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, the UK and Sweden: EpiLUTS. BJU Int 2009; 103 (Suppl. 3): 1223
  • 32
    Kupelian V, Rosen RC, Link CL et al. Association of urologic symptoms and chronic illnesses: contribution of symptom severity and duration: results from the Boston area community health (BACH) survey. J Urol 2009; 181: 694700
  • 33
    Coyne KS, Kaplan SA, Chapple CR et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int 2009; 103 (Suppl. 3): 2432.
  • 34
    Norman RW, Nickel JC, Fish D, Pickett SN. ‘Prostate-related symptoms’ in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Br J Urol 1994; 74: 54250
  • 35
    Coyne KS, Matza LS, Kopp ZS et al. Examining lower urinary tract symptom constellations using cluster analysis. BJU Int 2008; 101: 126773
  • 36
    Cinar A, Hall SA, Link CL et al. Cluster analysis and lower urinary tract symptoms in men: findings from the Boston Area Community Health Survey. BJU Int 2008; 101: 124756
  • 37
    Hall SA, Cinar A, Link CL et al. Do urological symptoms cluster among women? Results from the Boston Area Community Health Survey. BJU Int 2008; 101: 125766
  • 38
    Seim A, Hoyo C, Ostbye T, Vatten L. The prevalence and correlates of urinary tract symptoms in Norwegian men: the HUNT study. BJU Int 2005; 96: 8892
  • 39
    Parsons JK, Carter HB, Partin A et al. Metabolic factors associated with benign hyperplasia: the Baltimore Longitudinal Study of Aging. J Urol 2006; 175: 4323
  • 40
    Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 2006; 176: 15247
  • 41
    Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 2006; 154: 899906
  • 42
    Kupelian V, McVary KT, Kaplan SA et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health (BACH) survey. J Urol 2009; 181: 694700
  • 43
    Kupelian V, McVary KT, Barry MJ et al. Association of c-reactive protein and lower urinary tract symptoms in men and women: results from the Boston area community health (BACH) survey. Urology 2009 (in press)
  • 44
    Rosen R, Altwein J, Boyle P et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 63749
  • 45
    Rosen RC, Link CL, O’Leary MP, Giuliano F, Aiyer LP, Mollon P. Lower urinary tract symptoms and sexual health: the role of gender, lifestyle and medical comorbidities. BJU Int 2009; 103 (Suppl. 3): 4247
  • 46
    Wein AJ, Coyne KS, Tubaro A, Sexton CC, Kopp ZS, Aiyer LP. The impact of lower urinary tract symptoms on male sexual health: results from the epidemiology of lower urinary tract symptoms study: (EpiLUTS). BJU Int 2009; 103 (Suppl. 3): 3341
  • 47
    Litman HJ, McKinlay JB. The future magnitude of urological symptoms in the USA: projections using the Boston Area Community Health Survey. BJU Int 2007; 100: 8205
  • 48
    Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 2008; 101: 138895
  • 49
    Hall S, Link C, Tennstedt S et al. Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health Survey. BJU Int 2009 (in press)
  • 50
    Coyne KS, Wein AJ, Tubaro A et al. The burden of lower urinary tract symptoms (LUTS): evaluating the effect of LUTS on health-related quality of life, anxiety and depression. BJU Int 2009; 103 (Suppl. 3): 411
  • 51
    Irwin DE, Milsom I, Kopp Z, Abrams P. Symptom bother and health care-seeking behavior among individuals with overactive bladder. Eur Urol 2008; 53: 102937
  • 52
    Kopp Z, Irwin D, Agatep B, Milsom I, Abrams P. Worldwide prevalence of current and future individuals (≥20 years) with lower urinary tract symptoms including urinary incontinence and overactive bladder. In 4th International Consultation on Incontinence, Paris, France, 2008
  • 53
    Lemack GE. Assessing the natural history of lower urinary tract symptoms without incontinence in women: what have we learned and where are we headed? Eur Urol 2007; 52: 15768
  • 54
    Lee AJ, Garraway WM, Simpson RJ, Fisher W, King D. The natural history of untreated lower urinary tract symptoms in middle-aged and elderly men over a period of five years. Eur Urol 1998; 34: 32532
  • 55
    Temml C, Brossner C, Schatzl G, Ponholzer A, Knoepp L, Madersbacher S. The natural history of lower urinary tract symptoms over five years. Eur Urol 2003; 43: 37480
  • 56
    Grundy SM, Cleeman JI, Merz CN et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 72032
  • 57
    Landefeld CS, Bowers BJ, Feld AD et al. National Institutes of Health State-of-the-Science Conference Statement. Prevention of fecal and urinary incontinence in adults. Ann Intern Med 2008; 148: 44958